touchREVIEWS in Respiratory & Pulmonary Diseases is a peer-reviewed, free-to-access, bi-annual, international journal that aims to provide insightful and topical articles relevant to the day-to-day practice of busy physicians.
The journal is of interest to an international audience of physicians, healthcare professionals and researchers, providing practical advice relevant to the clinical setting on the diagnosis and treatment of respiratory conditions. touchREVIEWS in Respiratory & Pulmonary Diseases endeavours to support these professionals in continuously developing their knowledge, effectiveness and productivity.
Proton Pump Inhibitors and Risk of Infection: Is Suppression of Immune Defence Molecules to Blame?
touchREVIEWS in Respiratory & Pulmonary Diseases. 2021;6(1):Online ahead of journal publication
Proton pump inhibitors (PPIs) are a class of antacid drugs that are available by prescription and over-the-counter to treat gastro-oesophageal reflux disease in patients with a number of comorbidities, including chronic respiratory diseases, such as asthma, pulmonary arterial hypertension, chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.1 Although they are generally regarded as safe and effective […]
Non-tuberculous Mycobacteria Infection: A Neglected Disease in Bangladesh
touchREVIEWS in Respiratory & Pulmonary Diseases. 2021;6(1):Online ahead of publication
Despite huge strides in the fight against TB, the WHO’s Global Tuberculosis Report 2019 ranked Bangladesh sixth among the countries with the highest number of TB cases (4% of the global total), and seventh among the top 10 countries with the widest gap between notified and incident TB cases.1 Funding for TB programmes remains challenging and an obstacle […]
Nirsevimab: An Extended Half-life Monoclonal Antibody for the Prevention of Infant Respiratory Syncytial Virus Infection
touchREVIEWS in Respiratory & Pulmonary Medicine. 2021;6(1):Online ahead of publication
Respiratory syncytial virus (RSV) is a ubiquitous virus that causes annual epidemics of infection in young children in all parts of the world. In temperate regions, epidemics are seasonal, and predictable during the winter months. Approximately half of all infants develop their first RSV infection prior to their first birthday. By 24 months of age, […]
Sleep Disorders in Neuromuscular Diseases: Adaption in Care Provision During the COVID-19 Pandemic
touchREVIEWS in Respiratory & Pulmonary Medicine. 2021;6(1):Online ahead of journal publication
Sleep disturbances are exceedingly common and potentially morbid in patients with neuromuscular diseases (NMD).1 A constellation of physiologic changes occur in patients with NMDs which, in concert with normal physiologic changes during sleep, lead to decreased nocturnal ventilation that often precedes daytime hypoventilation. The standard manner in which we diagnose and treat sleep disorders in this […]
Home-based Screening for Obstructive Sleep Apnea in Children
US Respiratory and Pulmonary Diseases. 2020;5(1):38-42 DOI: https://doi.org/10.17925/USPRD.2020.5.1.38
Sleep disordered breathing in children comprises a spectrum of abnormal breathing patterns associated with increased airflow resistance and sleep disruption. Sleep disordered breathing is categorized by severity into primary snoring, upper airway resistance syndrome, and obstructive sleep apnea (OSA). Pediatric OSA has a prevalence of up to 5% in children.1 The most common cause of increased […]
Obesity Hypoventilation Syndrome—A Concise Clinical Review
US Respiratory and Pulmonary Diseases. 2020;5(1):43-7 DOI: https://doi.org/10.17925/USPRD.2020.5.1.43
Obesity hypoventilation syndrome (OHS) is defined as daytime hypercapnia (awake resting PaCO2 of ≥45 mmHg) in the setting of obesity (body mass index [BMI] ≥30 kg/m2). Most, if not all, patients have some sleep disordered breathing in the form of obstructive sleep apnea (OSA) or sleep-related hypoventilation. Alternative causes of hypoventilation, such as severe pulmonary disease, […]
Improvement of Chest Wall Compliance Immediately Following Subcutaneous Placement of Central Venous Catheter for Decompression of Massive Subcutaneous Emphysema
US Respiratory and Pulmonary Diseases. 2020;5(1):48-51 DOI: https://doi.org/10.17925/USPRD.2020.5.1.48
Subcutaneous emphysema (SE) is relatively common in the intensive care unit (ICU) and often a complication of positive pressure ventilation.1,2 While typically self-limiting and benign, life-threatening sequela can develop. Progressive accumulation of subcutaneous air can result in significant compressive forces leading to the development of a rare clinical entity known as massive subcutaneous emphysema (MSE). The […]
Considering the Impact of Type 2 Diabetes Mellitus—Biological Mechanisms in COVID-19 Pathology
US Respiratory and Pulmonary Diseases. 2020;5(1):24-7 DOI: https://doi.org/10.17925/USPRD.2020.5.1.24
The COVID-19 pandemic has infected more than 61 million people and led to more than 1 million deaths worldwide.1 The USA was one of the later countries to experience large scale community transmission; to date, there have been 13.2 million cases and approaching 300,000 deaths attributed to COVID-19.1 The USA has the highest overall deaths globally.1,2 The COVID-19 […]
Impact of Smoking and Tobacco use on the Severity of COVID-19 Infection
US Respiratory and Pulmonary Diseases. 2020;5(1):12-4 DOI: https://doi.org/10.17925/USPRD.2020.5.1.12
Smoking is a significant risk factor for severe COVID-19. A substantial amount of evidence supports the fact that tobacco use and chronic obstructive pulmonary disease (COPD) are among the strongest risk factors that lead to severe disease and high mortality due to COVID-19 illness. In a recent publication, Zhao et al. carried out a meta-analysis […]
Journal articles and more to your inbox
Get the latest clinical insights from touchRESPIRATORYSign me up!